A Pharmacokinetic and Clotting Activity Study of FVIII-PEGLip

Clinical trial NCT04592692 · UNKNOWN

Trial details

NCT number: NCT04592692
Sponsor: Ascension Healthcare Development Limited
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Hemophilia A With Inhibitor

Start date: 2019-12-23
Primary completion: 2022-02-28
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.